# Valion Bio, Inc. (VBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 797.4K | $ -648.5K | $ 987.9K | N/A | $ 5.82M |
| 2021 | $ 0 | $ -1.76M | $ -1.79M | $ 0 | $ -87.7K |
| 2020 | $ 0 | $ -1.62M | $ -2.27M | $ 23.2K | $ 1.11M |
| 2019 | $ 0 | $ -26.06M | $ -5.28M | $ 0 | $ 1.90M |
| 2018 | $ 39.6K | $ -6.03M | $ -4.15M | $ 0 | $ 15.87M |
| 2017 | $ 148.2K | $ -5.87M | $ -3.61M | $ 0 | $ 982.5K |
| 2016 | $ 261.4K | $ -6.73M | $ -1.51M | $ 0 | $ -681.2K |
| 2015 | $ 351.0K | $ -280.8K | $ -3.00M | $ 0 | $ -83.9K |
| 2014 | $ 268.5K | $ -6.56M | $ -3.36M | $ 0 | $ -491.4K |
| 2013 | $ 0 | $ -3.24M | $ -2.81M | $ 550.0K | $ 254.4K |
| 2012 | $ 0 | $ -3.17B | $ -2.00M | $ 125.79M | $ -379.6K |
| 2011 | $ 0 | $ -403.35M | $ -163.3K | $ 196.8K | $ -222.3K |
| 2010 | $ 0 | $ -78.57M | $ -45.8K | $ 71.80M | $ -73.6K |
| 2009 | $ 0 | $ 28.90M | $ -38.3K | $ 37.67M | $ -37.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 8.42 |
| Current Ratio | 0.30 |

## Other views

- [Metrics](https://sponda.capital/en/VBIO.md)
- [Charts](https://sponda.capital/en/VBIO/charts.md)
- [Compare](https://sponda.capital/en/VBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.